Combination of the structure-based design and solid-phase parallel synthesis provided an integrated approach to rapidly develop the structure–activity relationship of benzopyran COX-2 inhibitors. Binding free energies predicted by free energy perturbation theory yielded good agreement with experimental results. New potent and selective lead compounds with improved metabolic properties were identified.